HC Wainwright & Co. Assumes Autolus Therapeutics at Buy, Announces Price Target of $10
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsInitiationPrice Target
HC Wainwright & Co. analyst Douglas Tsao assumes Autolus Therapeutics (NASDAQ:AUTL) with a Buy rating and announces Price Target of $10.
HC Wainwright & Co. analyst Douglas Tsao assumes Autolus Therapeutics (NASDAQ:AUTL) with a Buy rating and announces Price Target of $10.